stearyl alcohol has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, B; Hu, F; Huang, X; Liu, N; Liu, X; Lu, B; Meng, T; Tan, Y; Yuan, H; Zhu, Y | 1 |
| Gupta, V; Liu, YY; Nazzal, S; Siddiqui, A | 1 |
2 other study(ies) available for stearyl alcohol and Ovarian Neoplasms
| Article | Year |
|---|---|
A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fatty Alcohols; Female; Glycolipids; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Mice; Mice, Nude; Micelles; Nanoparticles; Ovarian Neoplasms; Schiff Bases | 2017 |
Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES).
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Cetrimonium; Cetrimonium Compounds; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Fatty Alcohols; Female; Humans; Nanoparticles; Oligonucleotides, Antisense; Ovarian Neoplasms | 2012 |